Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
ABSTRACT Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has caused
devastating human and economic costs. Vaccination is an important step in controlling the …
devastating human and economic costs. Vaccination is an important step in controlling the …
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
PJ Halfmann, SJ Frey, K Loeffler, M Kuroda… - …, 2022 - thelancet.com
Background The COVID-19 pandemic continues to cause morbidity and mortality worldwide.
Most approved COVID-19 vaccines generate a neutralizing antibody response that primarily …
Most approved COVID-19 vaccines generate a neutralizing antibody response that primarily …
Significance of conserved regions in coronavirus spike protein for developing a novel vaccine against SARS-CoV-2 infection
Over the years, several distinct pathogenic coronaviruses have emerged, including the
pandemic SARS-CoV-2, which is difficult to curtail despite the availability of licensed …
pandemic SARS-CoV-2, which is difficult to curtail despite the availability of licensed …
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
JA Williams, M Biancucci, L Lessen, S Tian… - Science …, 2023 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern
challenge the efficacy of approved vaccines, emphasizing the need for updated spike …
challenge the efficacy of approved vaccines, emphasizing the need for updated spike …
The nuts and bolts of SARS-CoV-2 spike receptor-binding domain heterologous expression
M Maffei, LC Montemiglio, G Vitagliano, L Fedele… - Biomolecules, 2021 - mdpi.com
COVID-19 is a highly infectious disease caused by a newly emerged coronavirus (SARS-
CoV-2) that has rapidly progressed into a pandemic. This unprecedent emergency has …
CoV-2) that has rapidly progressed into a pandemic. This unprecedent emergency has …
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
H Kleanthous, JM Silverman, KW Makar, IK Yoon… - npj Vaccines, 2021 - nature.com
Vaccination of the global population against COVID-19 is a great scientific, logistical, and
moral challenge. Despite the rapid development and authorization of several full-length …
moral challenge. Despite the rapid development and authorization of several full-length …
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
W Zhou, W Wang - Signal transduction and targeted therapy, 2021 - nature.com
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is still threatening global health. According to the latest data, the number of …
(SARS-CoV-2) is still threatening global health. According to the latest data, the number of …
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
K Xu, P Gao, S Liu, S Lu, W Lei, T Zheng, X Liu, Y Xie… - Cell, 2022 - cell.com
Breakthrough infections by SARS-CoV-2 variants become the global challenge for
pandemic control. Previously, we developed the protein subunit vaccine ZF2001 based on …
pandemic control. Previously, we developed the protein subunit vaccine ZF2001 based on …
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein
mediates viral entry into cells expressing angiotensin-converting enzyme 2 (ACE2). The S …
mediates viral entry into cells expressing angiotensin-converting enzyme 2 (ACE2). The S …
A glycosylated RBD protein induces enhanced neutralizing antibodies against Omicron and other variants with improved protection against SARS-CoV-2 infection
ABSTRACT SARS-CoV-2 has mutated frequently since its first emergence in 2019.
Numerous variants, including the currently emerging Omicron variant, have demonstrated …
Numerous variants, including the currently emerging Omicron variant, have demonstrated …